Abstract:Cdc7p is a protein kinase that is required for G1yS transition and initiation of DNA replication in Saccharomyces cerevisiae. The mechanisms whereby Cdc7p and its substrates exerts their effects are unknown. We report here the characterization in S. cerevisiae of a recessive mutation in amember of theMCM family, MCM5yCDC46, which bypasses the requirement for Cdc7p and its interacting factor Dbf4p. Because the MCM family of evolutionarily conserved proteins have been implicated in restricting DNA replication to once per cell cycle, our studies suggest that Cdc7p is required late in G1 because in its absence the Mcm5pyCdc46p blocks the initiation of DNA replication. Moreover, Mcm5pyCdc46p may have both positive and negative effects on the ability of cell to initiate replication. Eukaryotic cells strictly limit the duplication of their genome. DNA replication initiates from sequences called origins no more than once per cell cycle. This regulation of origin usage results in the precise duplication of each of the cell’s chromosomes and a block to rereplication until the cell segregates its chromosomes during mitosis. An evolutionarily conserved family of genes, the MCM family are required for DNA replication (1–3). In Saccharomyces cerevisiae, the family of MCM proteins is comprised of six members including the Mcm2p (4, 5), Mcm3p (5), Mcm4py Cdc54p (6), Mcm5pyCdc46p (7, 8), Mcm6p (identified by the yeast genome project), andMcm7pyCdc47p (9, 10) all of which share a highly conserved 200-amino acid region (1, 2). Using Xenopus egg extracts, the MCM proteins have been linked biochemically to an activity which is able to modify or license replication–incompetent chromatin to a replication– competent state (11). Localization of the MCM proteins in yeast are cell cycle-regulated and are detected in the nucleus only from late in mitosis to early in S phase (5, 10, 12). While in the nucleus duringG1 theMCMproteins appear to be bound to chromatin (5). In mammalian and Xenopus cells, MCM proteins are present in the nucleus constitutively and the binding of the MCM proteins to chromatin is restricted to late in mitosis to early in S phase as DNA replication progresses (13–16). Two evolutionarily conserved kinases, the cyclin B(Clb)y cyclin-dependent kinase (Cdk) and Cdc7p, are required late in G1 to initiate DNA replication (3). The phosphorylation of Mcm4p by ClbyCdk appears to play a role in triggering the removal of the MCM proteins from chromatin (17). However the substrates and the mechanisms for the essential functions of Cdc7p are unknown. CDC7 is not required for premeiotic DNA replication, and its role in the mitotic cell cycle may not be limited to DNA replication as cdc7 mutants effect transcriptional repression at the HMR silent mating type locus (18–20). The kinase activity of the Cdc7p in S. cerevisiae is cell cycle-regulated with activity peaking late in G1 just prior to initiation of DNA replication (21, 22). Cdc7p interacts genetically with Orc2p, the second subunit of the origin recognition complex (ORC), and with Dbf4p, also an origin targeted factor (23–26). The Dbf4p also interacts with the Polo-like protein kinase Cdc5p (26). Dbf4p is required late in G1 and plays a role in activating Cdc7p (21). We report here the identification in S. cerevisiae of a recessive loss-of-function mutant mcm5y cdc46-bob1, which bypasses the requirement for Cdc7p and its interacting factor Dbf4p (21). This result suggests that one role for Cdc7p late in G1 is to remove or bypass a Mcm5pyCdc46p dependent block to the initiation of DNA replication. MATERIALS AND METHODS General Methods. The yeast strains were grown in yeast extractypeptoneydextrose with 2% glucose or in synthetic minimal media supplemented with appropriate amino acids and glucose. 5-Fluoro-orotic acid plates were made according to Boeke et al. (27). Yeast transformations were by the lithium acetate method, and general genetic manipulations were conducted as described previously (21, 24). YCp50-CDC46 (pRB541) contains a 15.6-kb fragment containing the wildtype CDC46 gene (7). pRS306-CDC46 (pCH781) was constructed by cloning the 1.1-kb BamHI CDC46 fragment from pRB541 into pRS306. Targeted integration was completed by linearizing pCH781 with SnaBI prior to transforming diploid strain YM1: dbf4-1ydbf4-1 cdc46-bob1yCDC46, to create a cdc46::URA3 disruption. pCH802 was constructed by cloning the 5.5-kb CDC46 fragment from pRB541 into pRS414. pCH813 was constructed by ligation of two CDC46 fragments derived from pCH802, a 2.5 kb SalI–SnaBI, and a 800-bp SnaBI–SacI into SalI–SmaI cut pRS414. pCH804 was generated by gap repair of pCH802 digested with MluIyAflII and transformed into strain P194 (dbf4-1 bob1-1). pCH804 was isolated from one of the temperature-resistant colonies. pCH824 contains the 3.3-kb SalI–SnaBIySnaBI–SacI fragment of cdc46-bob1 derived from pCH804 and cloned into pRS414. pCH819 contains the SalI–SnaBI wild-type CDC46 fragment from pCH802 and the 800-bp SnaBI–SacI cdc46bob1 mutant fragment from pCH804 cloned into pRS414. pCH823 contains the 2.5-kb SalI–SnaBI cdc46-bob1 mutant gene fragment from pCH802 and the 800-bp SnaBI–SacI wild-type CDC46 gene fragment from pCH804 cloned into pRS414. pCH822 contains the 1.6-kb SalI–BamHI cdc46-bob1 mutant gene fragment from pCH802 and the 900-bp BamHI– SnaBI and 800-bp SnaBI–SacI wild-type CDC46 gene fragments from pCH804 cloned into pRS414. The SalI–BamHI fragment in pcdc46-bob was sequenced with Sequenase (United States Biochemical) on double-stranded templates. The The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked ‘‘advertisement’’ in accordance with 18 U.S.C. §1734 solely to indicate this fact. Copyright q 1997 by THE NATIONAL ACADEMY OF SCIENCES OF THE USA 0027-8424y97y943151-5$2.00y0 PNAS is available online at http:yywww.pnas.org. Abbreviations: FACS, fluorescence-activated cell sorter; Cdk, cyclindependent kinase; cM, centimorgan. †To whom reprint requests should be addressed. e-mail: chardy@ cellbio.wustl.edu.

Effect of oestrogen status on serum levels of growth hormone‐binding protein and insulin‐like growth factor‐I in non‐pregnant and pregnant women

When one size does not fit all: aid and health system strengthening for Small Island Developing States

Chronic Diseases: Chronic Diseases and Development 4 Prevention and management of chronic disease: a litmus test for health-systems strengthening in low-income and middle-income countries

Rebuilding and strengthening health systems and providing basic health services in fragile states

Health system strengthening in fragile and conflict-affected states: A review of systematic reviews

Beyond the building blocks: integrating community roles into health systems frameworks to achieve health for all

Strengthening district health management and planning: an evaluation of a multi-country initiative in Eastern and Southern Africa

Improving the long-term sustainability of health aid: are Global Health Partnerships leading the way?

Differential regulation of microglial NO production by protein kinase C inhibitors

Twelfth-grade student work intensity linked to later educational attainment and substance use: new longitudinal evidence.

Self-Determination in Global Health Practices – Voices from the Global South

Global health systems strengthening: FIGO's strategic view on reducing maternal and newborn mortality worldwide

The GAVI Alliance and the 'Gates approach' to health system strengthening

mcm 5 y cdc 46-bob 1 bypasses the requirement for the S phase activator Cdc 7 p

Context and priorities for health systems strengthening for pain and disability in low- and middle-income countries: a secondary qualitative study and content analysis of health policies

Strategic Alliances in Global Health: Innovative Perspectives in the Era of Sustainable Development

Feasibility of health systems strengthening in South Sudan: a qualitative study of international practitioner perspectives

Keyhole limpet hemocyanin (KLH): a biomedical review.

Health systems strengthening to arrest the global disability burden: empirical development of prioritised components for a global strategy for improving musculoskeletal health

Emerging Lessons from the Development of National Health Financing Strategies in Eight Developing Countries

Seven challenges in international development assistance for health and ways forward